Lixisenatide · source year

Lixisenatide research records in 2025

6 selected, source-linked Lixisenatide records carrying a 2025 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

6 selected records.

Evidence types

3 represented types.

Cited sources

6 distinct public records.

Explore 2025 by evidence type

3 types

Cited chronology

Lixisenatide records dated 2025

Open in the filterable feed →

November 2025

1 record

August 2025

1 record

June 2025

1 record

January 2025

3 records

Literature metadata

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981945 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981946 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981947 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗